Rani Therapeutics (RANI) vs Vivani Medical (VANI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Rani Therapeutics (RANI) has outperformed Vivani Medical (VANI) over the past year, gaining 61.6% versus a loss of 10.9%. Over five years, VANI leads with a -86.0% price change compared with -96.0% for RANI. Rani Therapeutics is the larger company by market cap ($111.3 million vs $111.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RANI | VANI |
|---|---|---|
| Share price | $0.792 | $1.23 |
| Market cap | $111.29M | $110.95M |
| 1-day change | -2.48% | -3.15% |
| YTD return | -41.33% | 0.00% |
| 1-year return | +61.63% | -10.87% |
| 5-year return | -95.98% | -85.96% |
| EPS (TTM) | $-0.15 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.87 | $1.92 |
| 52-week low | $0.445 | $0.923 |
| Distance from 52-week high | -79.53% | -35.94% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +809.09% | +211.38% |
| Average volume | 746.05K | 243.63K |
| Shares outstanding | 115.42M | 90.20M |
| Employees | 69 | 42 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RANI has outperformed VANI by 72.5 percentage points over the past year.
About Rani Therapeutics
RANI stock →Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.
Healthcare · Biotechnology · 69 employees
About Vivani Medical
VANI stock →Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.
Healthcare · Biotechnology · 42 employees
RANI vs VANI FAQ
Which is bigger, Rani Therapeutics or Vivani Medical?
Rani Therapeutics (RANI) is larger, with a market capitalization of $111.29M compared with $110.95M for Vivani Medical (VANI).
Which stock has performed better over the past year, RANI or VANI?
RANI returned +61.63% over the past 12 months, compared with -10.87% for VANI (price return, excluding dividends). Past performance does not predict future results.
Are Rani Therapeutics and Vivani Medical in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.